Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nektar Therapeutics
Pharma
Nektar extends cash runway with $90M manufacturing plant sale
Nektar is selling its Alabama manufacturing plant and reagent supply business to private equity firm Ampersand for a total value of $90 million.
Fraiser Kansteiner
Nov 4, 2024 1:16pm
'The Top Line': Pharma ads, Novartis' M&A czar and more
Apr 29, 2022 3:00am
Faulty manufacturing trips up Nektar's BMS-partnered cancer drug
Aug 9, 2019 11:25am
Takeda-Shire, Nektar, Daiichi and more—FiercePharmaAsia
Apr 27, 2018 9:34am
